ADR-AC GmbH
Matteo Prezzi is the General Manager of ADR-AC GmbH, a prominent center of excellence in cellular immunology and drug hypersensitivity. Prior to this role, Matteo held positions such as Director Of Business Development at Chemspeed Technologies AG and Head of Sales at SAFE Nanotechnologies, successfully growing businesses and establishing strategic partnerships. With a background in business administration, Matteo has a track record of driving business growth and leading teams to success.
This person is not in any teams
ADR-AC GmbH
The Company was founded by Prof. Dr. med. W. J. Pichler and based on a unique combination of clinical and experimental experience in the field of drug hypersensitivity. We offer: Contract research: ADR-AC offers defined, case-related risk assessment to analyze and evaluate the immune-stimulatory potential of culprit substances. Routine diagnostic services: we perform various diagnostic tests with patient samples on a daily or bi-weekly basis to confirm or rule out drug-mediated hypersensitivity reactions. Contact us: info@adr-ac.ch